Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-25,727	Closed	-$1.1M	–	34
2017 Q3	$1.1M	Hold	25,727	–	–	1.23%	20
2017 Q2	$1.11M	Buy	+25,727	New	+$1.08M	1.23%	21
2016 Q4	–	Sell	-41,949	Closed	-$1.85M	–	35
2016 Q3	$1.85M	Buy	41,949 +535	+1%	+$24.3K	2.03%	20
2016 Q2	$1.73M	Hold	41,414	–	–	1.66%	23
2016 Q1	$1.67M	Hold	41,414	–	–	1.57%	22
2015 Q4	$2.12M	Buy	+41,414	New	+$2.11M	1.49%	25

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's XPH Position: Q4 2017 in Review

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2017, closing a stake of 25,727 shares — an estimated $1.1M sold.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in XPH in Q4 2015 and held it in 6 quarters. The position peaked at $2.12M in Q4 2015. 85 funds tracked by Wall St. Rank hold XPH as of Q4 2017.

Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet sold 25,727 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2017, an estimated $1.1M.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2015 and held it in 6 quarters.
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.12M in Q4 2015.
85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2017.

Based on Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet's 13F filing for Q4 2017, filed 5 Feb 2018.